image
Healthcare - Biotechnology - NASDAQ - GB
$ 0.3
-0.892 %
$ 76.8 M
Market Cap
-1.0
P/E
INCOME STATEMENT
178 M REVENUE
195.34%
-68.8 M OPERATING INCOME
50.19%
-70.8 M NET INCOME
37.81%
EFFICIENCY
Earnings Waterfall Adaptimmune Therapeutics plc
image
Revenue 178 M
Cost Of Revenue 70 K
Gross Profit 178 M
Operating Expenses 247 M
Operating Income -68.8 M
Other Expenses 2.05 M
Net Income -70.8 M
200m200m150m150m100m100m50m50m00(50m)(50m)(100m)(100m)178m(70k)178m(247m)(69m)(2m)(71m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Jun-2015 Jun-2014 Jun-2013
REVENUE
Revenue 178.0 60.3 27.1 6.1 4.0 1.1 59.5 37.8 14.2 10.7 0.6 0
GROSS PROFIT
Cost Of Revenue 70 K 9.9 127.7 111.1 91.6 97.5 0 0 0 0 0 0
Gross Profit 178.0 50.4 (100.6) (104.9) (87.6) (96.4) 59.5 37.8 14.2 10.7 0.6 0
OPERATING INCOME
Operating Expenses 246.7 188.4 191.1 168.4 137.4 140.9 141.9 118.5 87.0 33.8 15.0 9.4
Selling, General and Administrative Expenses 81.3 71.8 63.4 57.3 45.8 43.4 43.6 31.1 23.2 11.3 2.7 1.2
Research and Development Expenses 149.1 126.5 127.7 111.1 91.6 97.5 98.3 87.4 63.8 23.2 12.5 8.1
Operating Income (68.8) (138.0) (164.0) (162.2) (133.4) (139.8) (82.4) (80.7) (72.8) (23.1) (14.4) (9.4)
PRE-TAX INCOME
Interest Income Expense 3.3 0 0 0 0 0 0.4 2.2 0 0 6.81 K 6.08 K
Total Other Income 1.5 25.5 (1.3) 4.9 3.5 2.8 (12.7) 11.0 2.1 (3.2) 2.8 5 K
Pre-Tax Income (67.2) (112.5) (163.0) (157.3) (129.9) (136.9) (95.0) (69.7) (70.7) (23.7) (14.4) (9.3)
NET INCOME
Tax Provision 3.6 1.3 2.5 0.8 0.2 0.2 0.5 0.5 0.9 (2.1) (1.7) (0.9)
Net Income (70.8) (113.9) (165.5) (158.1) (130.1) (137.2) (95.5) (70.1) (71.6) (21.6) (12.7) (8.5)
EPS 0.28 0.57 1.02 1.02 0.9 1.32 0.96 0.78 1.02 0.6 0.25 0.5